Business Wire (Free subscription) | yesterday
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting
Pharmalot (Free subscription) | yesterday
Pfizer was handed a record $200,000 fine after its reps wrongly told doctors that a rival drug was dangerous, and the penalty formed part of a record $1.8 million of fines handed down to some of the world’s largest drugmakers, including Glaxo and Roche, by the Medicines Australia trade group, The Age reports. Many of the [...]
Seeking Alpha (Free subscription) | yesterday
Mike Huckman submits: Previously I posited a theory that the weak American economy might be hurting sales growth of erectile dysfunction drugs . The drugs are so pricey and may not be covered by insurance, so I wondered whether men might be cutting their pills in half and/or not filling their expensive prescriptions if they're having to tighten their belts. Complete Story »
Seeking Alpha (Free subscription) | yesterday
J Clinton Hill submits: Pfizer (PFE) is hard pressed to generate growth as it deals with lack of a significant pipeline and stands to lose Lipitor’s exclusive patent in March 2010. After a series of disappointments with Torcetrapib, Asenapine, Promune, Exubera, Dalbavancin and Tremelimumab, many investors have abandoned the stock. To address its bottom line over the near-term, PFE is currently engaged...
The St Louis Business Journal (Free subscription) | 07/24/2008
Pfizer Inc.'s profit more than doubled in the second quarter, reflecting growth in international pharmaceutical sales, the drug giant said Wednesday. (PFE)
AAPL - BloggingStocks (Free subscription) | 7 hours ago
Filed under: Earnings reports , Yahoo! (YHOO) , Apple Inc (AAPL) , Pfizer (PFE) , PepsiCo (PEP) , Amazon.com (AMZN) , Ford Motor (F) , McDonald's (MCD) , Caterpillar (CAT) , American Express (AXP) , Bank of America (BAC) , Boeing Co (BA) , Hershey Co (HSY) , Kimberly-Clark (KMB) , Wachovia Corp (WB) , Washington Mutual (WM) , Merck and Co (MRK) , UAL Corp (UAUA) , Texas Instruments (TXN) , Crocs Inc...
Business Spectator (Free subscription) | yesterday
Pfizer brings discredit to the industry, says Medicines Australia. 26 Jul 2008 2:29 AM
Fiercebiotech (Free subscription) | yesterday
Pfizer might have felt singled out a while back when Sen. Sherrod Brown demanded details of its outsourcing program. How much, the senator wanted to know, of the company's outsourcing went to countries with less stringent oversight? Well, now Pfizer isn't alone: The senator has sent Merck a letter asking for similar information. And as in Pfizer's case, the request follows a statement from a company...
Medical News Today (Free subscription) | yesterday
Pfizer's erectile dysfunction medication Viagra can improve sexual function for some women who take antidepressants, according to a study published Wednesday in the Journal of the American Medical Association, the Baltimore Sun reports (Kohn, Baltimore Sun, 7/23).
The Age (Free subscription) | yesterday
Drugs giant Pfizer hit with record $200,000 fine and found guilty of bringing discredit to the industry.
Nurnberg (Free subscription) | yesterday
Women who lose their sexual appetite as a side effect of taking antidepressant could easily gain it back if using Pfizer Inc.’s Viagra, usually prescribed ...
Illinois Medical Malpractice Blog (Free subscription) | 07/24/2008
Pfizer and Boehringer-Ingelheim have been called before a federal court following a class action lawsuit for the negligent manufacture and distribution of Mirapex , a drug recently given to patients suffering from Parkinson’s disease and Restless Leg Syndrome . The lawsuit arose after two studies, one in 2003 by the Muhammad Ali Parkinson Research Center at Barrow Neurological Institute in Arizona...
Fool.com (Free subscription) | 07/24/2008
The drugmaker posts strong earnings, but the good times may not last.
atHome Top Story (Free subscription) | 07/24/2008
Pfizer Inc. said yesterday its second-quarter profit more than doubled as restructuring charges declined and the weak U.S. dollar helped lift overseas revenue, offsetting new generic competition and enabling the company to just beat Wall Street expectations.
Seeking Alpha (Free subscription) | 07/24/2008
Mike Huckman submits: On the Pfizer (PFE) earnings conference call yesterday morning, Chairman and CEO Jeff Kindler kicked things off by calling this a "time of great uncertainty in the world economy and capital markets and significant challenges in our industry." As a Pfizer PR person pointed out in an email following my earnings story on "Squawk on the Street" yesterday morning, worldwide Viagra...
The last article published by a user on Pfizer Inc. :
nitesh | 11/01/2007
China is expected to become the fifth largest drug market in the world by 2010 with a growth rate of 20-25 percent per annum in next three years. As China joins the World Trade Organization (WTO) and integrates more completely into the global economy, it will further open the door to a lucrative drug market for overseas pharmaceutical companies, which attracts more and more overseas pharmaceutical...
